| 2025-11-19 |
详情>>
业绩披露：
2025年三季报(累计)每股收益0.60美元,归母净利润2234.50万美元,同比去年增长407.06%
|
| 2025-11-19 |
财报披露：
美东时间 2025-11-19 盘前发布财报
|
| 2025-08-13 |
详情>>
业绩披露：
2025年中报每股收益0.51美元,归母净利润1880.80万美元,同比去年增长336.01%
|
| 2025-06-05 |
股东大会：
将于2025-07-16召开股东大会
会议内容 ▼▲
- 1.Approve and ratify the re-appointment of Kesselman & Kesselman, a member firm of PricewaterhouseCoopers International Limited, as the Company’s independent registered public accounting firm for the year ending December 31, 2025, and until the next annual general meeting of shareholders, and to authorize the Company’s Board of Directors, following the approval of the Audit Committee, to approve and ratify the remuneration of such firm in accordance with the volume and nature of their services.
2.Elect each of the following nominees to the Board of Directors of the Company, to hold office until close of the Company’s annual general meeting to be held in 2026:
a.Mr. Yair Nechmad;
b.Mr. David Ben-Avi;
c.Mr. Nir Dor;
d.Mr. Reuven Ben Menachem;
e.Mr. Eran Havshush.
|
| 2025-06-05 |
股东大会：
将于2025-07-16召开股东大会
会议内容 ▼▲
- 1.Approve and ratify the re-appointment of Kesselman & Kesselman, a member firm of PricewaterhouseCoopers International Limited, as the Company’s independent registered public accounting firm for the year ending December 31, 2025, and until the next annual general meeting of shareholders, and to authorize the Company’s Board of Directors, following the approval of the Audit Committee, to approve and ratify the remuneration of such firm in accordance with the volume and nature of their services.
2.Elect each of the following nominees to the Board of Directors of the Company, to hold office until close of the Company’s annual general meeting to be held in 2026:
a.Mr. Yair Nechmad;
b.Mr. David Ben-Avi;
c.Mr. Nir Dor;
d.Mr. Reuven Ben Menachem;
e.Mr. Eran Havshush.
|
| 2025-06-05 |
详情>>
股本变动：
变动后总股本3693.82万股
|
| 2025-05-13 |
详情>>
业绩披露：
2025年一季报每股收益0.20美元,归母净利润715.60万美元,同比去年增长244.39%
|
| 2025-03-04 |
详情>>
业绩披露：
2022年年报每股收益-1.14美元,归母净利润-3750.9万美元,同比去年增长-51.47%
|
| 2025-03-04 |
详情>>
业绩披露：
2024年年报每股收益-0.16美元,归母净利润-563.1万美元,同比去年增长64.56%
|
| 2024-11-12 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-0.2美元,归母净利润-727.7万美元,同比去年增长42.22%
|
| 2024-08-07 |
详情>>
业绩披露：
2024年中报每股收益-0.23美元,归母净利润-796.9万美元,同比去年增长16.12%
|
| 2024-05-30 |
股东大会：
将于2024-07-10召开股东大会
会议内容 ▼▲
- 1.Approve and ratify the re-appointment of Kesselman & Kesselman, a member firm of PricewaterhouseCoopers International Limited, as the Company’s independent registered public accounting firm for the year ending December 31, 2024, and until the next annual general meeting of shareholders, and to authorize the Company’s Board of Directors, following the approval of the Audit Committee, to approve and ratify the remuneration of such firm in accordance with the volume and nature of their services.
2.Elect each of the following nominees to the Board of Directors of the Company, to hold office until close of the Company’s annual general meeting to be held in 2025, and until the respective successor of each of the nominees is duly elected and qualified: a.Mr. Yair Nechmad; b.Mr. David Ben-Avi; c.Mr. Nir Dor; d.Mr. Reuven Ben Menachem; and e.Mr. Eran Havshush.
3.Elect each of the following nominees as an external director of the Company, each for a three-year term, subject to, and in accordance with, the provisions of the Israeli Companies Law, 5759-1999, or the Companies Law: a.Ms. Rina Shafir; and b.Ms. Vered Raz Avayo.
|
| 2024-05-30 |
股东大会：
将于2024-07-10召开股东大会
会议内容 ▼▲
- 1.Approve and ratify the re-appointment of Kesselman & Kesselman, a member firm of PricewaterhouseCoopers International Limited, as the Company’s independent registered public accounting firm for the year ending December 31, 2024, and until the next annual general meeting of shareholders, and to authorize the Company’s Board of Directors, following the approval of the Audit Committee, to approve and ratify the remuneration of such firm in accordance with the volume and nature of their services.
2.Elect each of the following nominees to the Board of Directors of the Company, to hold office until close of the Company’s annual general meeting to be held in 2025, and until the respective successor of each of the nominees is duly elected and qualified: a.Mr. Yair Nechmad; b.Mr. David Ben-Avi; c.Mr. Nir Dor; d.Mr. Reuven Ben Menachem; and e.Mr. Eran Havshush.
3.Elect each of the following nominees as an external director of the Company, each for a three-year term, subject to, and in accordance with, the provisions of the Israeli Companies Law, 5759-1999, or the Companies Law: a.Ms. Rina Shafir; and b.Ms. Vered Raz Avayo.
|
| 2024-05-15 |
详情>>
业绩披露：
2024年一季报每股收益-0.15美元,归母净利润-495.6万美元,同比去年增长10.33%
|
| 2024-02-28 |
详情>>
业绩披露：
2023年年报每股收益-0.48美元,归母净利润-1588.7万美元,同比去年增长57.64%
|
| 2023-11-07 |
详情>>
业绩披露：
2023年三季报(累计)每股收益-0.38美元,归母净利润-1259.4万美元,同比去年增长58.01%
|
| 2023-10-25 |
复牌提示：
2023-10-25 10:12:34 停牌，复牌日期 2023-10-25 10:17:34
|
| 2023-07-26 |
股东大会：
将于2023-09-12召开股东大会
会议内容 ▼▲
- 1.Approve and ratify the re-appointment of Kesselman & Kesselman, a member firm of PricewaterhouseCoopers International Limited, as the Company’s independent registered public accounting firm for the year ending December 31, 2023, and until the next annual general meeting of shareholders, and to authorize the Company’s Board of Directors, following the approval of the Audit Committee, to approve and ratify the remuneration of such firm in accordance with the volume and nature of their services.
2.Re-elect each of the following nominees to the Board of Directors of the Company, to hold office until close of the Company’s annual general meeting to be held in 2024, and until the respective successor of each of the nominees is duly elected and qualified.
3.Remuneration of relatives of the controlling shareholders.
|
| 2023-07-26 |
股东大会：
将于2023-09-12召开股东大会
会议内容 ▼▲
- 1.Approve and ratify the re-appointment of Kesselman & Kesselman, a member firm of PricewaterhouseCoopers International Limited, as the Company’s independent registered public accounting firm for the year ending December 31, 2023, and until the next annual general meeting of shareholders, and to authorize the Company’s Board of Directors, following the approval of the Audit Committee, to approve and ratify the remuneration of such firm in accordance with the volume and nature of their services.
2.Re-elect each of the following nominees to the Board of Directors of the Company, to hold office until close of the Company’s annual general meeting to be held in 2024, and until the respective successor of each of the nominees is duly elected and qualified.
3.Remuneration of relatives of the controlling shareholders.
|